SINT Sintofarm SA Bucuresti
Listings ·
SINTX Technologies received a Nasdaq notice on May 22, 2026 that its stockholders' equity, about $904,000 at March 31, 2026, is below the $2.5 million minimum. It has until July 6, 2026 to submit a plan to regain compliance, and its 2025 annual report carries a going-concern paragraph.
SINTX (Nasdaq: SINT) sold shares, pre-funded warrants and warrants for gross proceeds of $5.0 million before fees. H.C. Wainwright & Co. was placement agent, and the company will use net proceeds for working capital.
Our latest story on this, dated May 27, 2026: "SINTX Technologies gets Nasdaq stockholders' equity deficiency notice, plan due July 6, 2026". The story links the filing or release it is based on. Read the story.
Our latest story on this, dated Feb 26, 2025: "SINTX Technologies closes $5.0 million private placement with warrants". The story links the filing or release it is based on. Read the story.
Our latest story on this, dated May 27, 2026: "SINTX Technologies gets Nasdaq stockholders' equity deficiency notice, plan due July 6, 2026". The story links the filing or release it is based on. Read the story.
Sintofarm SA Bucuresti trades under the ticker SINT on BVB.
Sintofarm SA Bucuresti is listed on BVB.
Our directory records Sintofarm SA Bucuresti under Romania.
Our directory classifies Sintofarm SA Bucuresti as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.
The ISIN recorded for Sintofarm SA Bucuresti is ROSINTACNOR6.
aibio.space lists Sintofarm SA Bucuresti among 2,820 public biotech companies and publishes its news here as stories appear.
Our latest story on Sintofarm SA Bucuresti, dated May 27, 2026: "SINTX Technologies gets Nasdaq stockholders' equity deficiency notice, plan due July 6, 2026". SINTX Technologies received a Nasdaq notice on May 22, 2026 that its stockholders' equity, about $904,000 at March 31, 2026, is below the $2.5 million minimum. It has until July 6, 2026 to submit a plan to regain compliance, and its 2025 annual report carries a going-concern paragraph. Source.
From our story of May 27, 2026: It has until July 6, 2026 to submit a plan to regain compliance, and its 2025 annual report carries a going-concern paragraph. Source.
Companies in our directory listed in the same country and business area as Sintofarm SA Bucuresti: Antibiotice SA.
Press Follow on this page to add Sintofarm SA Bucuresti to your Following list, or subscribe to the aibio.space newsletter. We have published 2 stories naming Sintofarm SA Bucuresti so far, in Financings, Listings.
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio